Budget Amount *help |
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2012: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2011: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2010: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
Research Abstract |
Community-acquired MRSA (CA-MRSA) has a stronger virulence than Healthcare-assiciated MRSA. Production of Panton-Valentine Leukocidin (PVL) is deemed to be responsible for the strong virulence.However, it was not clear that PVL alone could explain the strong virulence of CA-MRSA. We noticed that CA-MRSA strain MW2 produced another set of leukocidins MW1941/1942. We expressed the toxins in E. coli, purified the toxin proteins and measured their lytic activity against human leukocytes. We observed a synergistic lytic activity of PVL and MW1941/1942 against human leukocytes.
|